Antioxidant effects of 1,4-dihydropyridine and nitroso aryl derivatives on the Fe+3/ascorbate-stimulated lipid peroxidation in rat brain slices

被引:48
作者
Díaz-Araya, G
Godoy, L
Naranjo, L
Squella, JA
Letelier, ME
Núñez-Vergara, L
机构
[1] Univ Chile, Fac Chem & Pharmaceut Sci, Pharmacol Lab, Santiago, Chile
[2] Univ Chile, Fac Chem & Pharmaceut Sci, Lab Bioelectrochem, Santiago, Chile
来源
GENERAL PHARMACOLOGY | 1998年 / 31卷 / 03期
关键词
nitroaryl 1,4-dihydropyridines; nitroso derivatives; lipoperoxidation; antioxidant;
D O I
10.1016/S0306-3623(98)00034-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Lipid peroxidation in rat brain slices was induced by Fe+3/ascorbate. 2. Brain lipid peroxidation, as measured by malondialdehyde formation, was inhibited by all the tested nitro aryl 1,4-dihydropyridine derivatives over a wide range of concentrations. The time-course antioxidant effects of the most representative agents were assessed. On the basis of both time-course and IC50 experiments the tentative order of antioxidant activity on rat brain slices could be: nicardipine>nisoldipine>(R,S/S,R)-furnidipine> (R,R/S,S)-furnidipine>nitrendipine>nimodipine>nifedipine. 3. 1,4-Dihydropyridine derivatives that lack of a nitro group in the molecule (isradipine, amlodipine) also inhibited lipid peroxidation in rat brain slices but at higher concentrations than that of nitrosubstituted derivatives. 4. All the tested nitroso aryl derivatives [2,6-dimethyl-4-(2-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester (NTP), nitrosotoluene, nitrosobenzene] were more potent inhibitors of lipid peroxidation than were the parent nitro compounds. In conclusion, on the basis of the IC50 values determined, the rank order of antioxidant potency for these derivatives can be established as: ortho nitrosotoluene>NTP>nitrosobenzene. GEN PHARMAC 31;3:385-391, 1998. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:385 / 391
页数:7
相关论文
共 34 条
  • [1] Andorn AC, 1996, J NEUROCHEM, V67, P717
  • [2] ANDORN AC, 1988, MOL PHARMACOL, V33, P152
  • [3] THE ANTIOXIDANT ROLE OF VITAMIN-C
    BENDICH, A
    MACHLIN, LJ
    SCANDURRA, O
    BURTON, GW
    WAYNER, DDM
    [J]. ADVANCES IN FREE RADICAL BIOLOGY AND MEDICINE, 1986, 2 (02): : 419 - 444
  • [4] BERGMEYER H.U., 1974, METHODS ENZYMATIC AN, P574, DOI DOI 10.1016/B978-0-12-091302-2.50010-4
  • [5] DIFFUSION OF DIHYDROPYRIDINE CALCIUM-CHANNEL ANTAGONISTS IN CARDIAC SARCOLEMMAL LIPID MULTIBILAYERS
    CHESTER, DW
    HERBETTE, LG
    MASON, RP
    JOSLYN, AF
    TRIGGLE, DJ
    KOPPEL, DE
    [J]. BIOPHYSICAL JOURNAL, 1987, 52 (06) : 1021 - 1030
  • [6] A COMPARATIVE INVITRO STUDY OF TRANSDERMAL ABSORPTION OF A SERIES OF CALCIUM-CHANNEL ANTAGONISTS
    DIEZ, I
    COLOM, H
    MORENO, J
    OBACH, R
    PERAIRE, C
    DOMENECH, J
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (10) : 931 - 934
  • [7] INHIBITION OF RAT-HEART AND LIVER MICROSOMAL LIPID-PEROXIDATION BY NIFEDIPINE
    ENGINEER, F
    SRIDHAR, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (08) : 1279 - 1285
  • [8] CARDIOPROTECTION BY NISOLDIPINE - ROLE OF TIMING OF ADMINISTRATION
    FERRARI, R
    CURELLO, S
    CECONI, C
    CARGNONI, A
    PASINI, E
    VISIOLI, O
    [J]. EUROPEAN HEART JOURNAL, 1993, 14 (09) : 1258 - 1272
  • [9] FLOYD RA, 1984, FREE RADICALS MOL BI, P143
  • [10] FLYNN CJ, 1989, BASIC NEUROCHEMISTRY, P783